Lancet Diabetes Endocrinol 5(4):251260 Aroda VR, Bain SC, Cariou B, Pileti M, Rose L, Axelsen M, Rowe E, DeVries JH (2017) Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
Two New Faces of Amifostine: Protector from DNA Damage in Normal Cells and Inhibitor of DNA Repair in Cancer Cells
Semaglutide with glycine combinations have also gained attention for potential benefits in muscle preservation
With that in mind, Valley Integrative Medicine in Roanoke, Virginia is happy to announce our Semaglutide Medical Weight Loss Program